Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of General Physiology|October 25, 2018
Chromomycin A<sub>2</sub> potently inhibits glucose-stimulated insulin secretion from pancreatic β cellsMichael A Kalwat, In Hyun Hwang, Jocelyn Macho, et al.
ACS Chemical Biology|February 2, 2016
Isoxazole Alters Metabolites and Gene Expression, Decreasing Proliferation and Promoting a Neuroendocrine Phenotype in β-CellsMichael A Kalwat, Zhimin Huang, Chonlarat Wichaidit, et al.
Science Translational Medicine|January 10, 2020
Pancreatitis is an FGF21-deficient state that is corrected by replacement therapyGenaro Hernandez, Ting Luo, Tanveer A Javed, et al.
Molecular Metabolism|January 13, 2024
RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetesNoyonika Mukherjee, Christopher J Contreras, Li Lin, et al.
Frontiers in Endocrinology|May 8, 2023
Small molecule glucagon release inhibitors with activity in human isletsMichael A Kalwat, Karina Rodrigues-Dos-Santos, Derk D Binns, et al.
ACS Sensors|November 8, 2016
Insulin promoter-driven Gaussia luciferase-based insulin secretion biosensor assay for discovery of β-cell glucose-sensing pathwaysMichael A Kalwat, Chonlarat Wichaidit, Alejandra Y Nava Garcia, et al.
Endocrinology|May 31, 2022
Small Molecule-mediated Insulin Hypersecretion Induces Transient ER Stress Response and Loss of Beta Cell FunctionKarina Rodrigues-Dos-Santos, Gitanjali Roy, Derk D Binns, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Target deconvolution of an insulin hypersecretion-inducer acting through VDAC1 with a distinct transcriptomic signature in beta-cellsGitanjali Roy, Andrea Ordóñez, Derk D Binns, et al.
Cell Reports|June 13, 2025
VDAC1 is a target for pharmacologically induced insulin hypersecretion in β cellsGitanjali Roy, Andrea Ordóñez, Derk D Binns, et al.
Pageof 3